Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant NetworkMARCHESI, Francesco; GIANNOTTI, Federica; D'ANDREA, Mariella et al.American journal of hematology. 2012, Vol 87, Num 2, pp 213-217, issn 0361-8609, 5 p.Article

Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilizationROMEO, Azzurra; CHIERICHINI, Anna; TOGLIA, Giuseppe et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 11, pp 2432-2446, issn 0041-1132, 15 p.Article